Form 8-K - Current report:
SEC Accession No. 0001493152-24-051890
Filing Date
2024-12-23
Accepted
2024-12-23 17:29:18
Documents
19
Period of Report
2024-12-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54101
2 ex4-1.htm EX-4.1 111965
3 ex4-2.htm EX-4.2 111629
4 ex5-1.htm EX-5.1 13810
5 ex10-1.htm EX-10.1 275484
6 ex99-1.htm EX-99.1 16529
7 ex5-1_001.jpg GRAPHIC 14287
  Complete submission text file 0001493152-24-051890.txt   905108

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE vvos-20241223.xsd EX-101.SCH 3006
9 XBRL LABEL FILE vvos-20241223_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE vvos-20241223_pre.xml EX-101.PRE 24159
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 241575038
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)